"Plasma Kallikrein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptidohydrolytic enzyme that is formed from PREKALLIKREIN by FACTOR XIIA. It activates FACTOR XII; FACTOR VII; and PLASMINOGEN. It is selective for both ARGININE and to a lesser extent LYSINE bonds. EC 3.4.21.34.
| Descriptor ID |
D020842
|
| MeSH Number(s) |
D08.811.277.656.300.760.442.700 D08.811.277.656.959.350.442.700
|
| Concept/Terms |
Plasma Kallikrein- Plasma Kallikrein
- Kallikrein, Plasma
- Serum Kallikrein
- Kallikrein, Serum
- Kininogenin
- Kallikrein I
|
Below are MeSH descriptors whose meaning is more general than "Plasma Kallikrein".
Below are MeSH descriptors whose meaning is more specific than "Plasma Kallikrein".
This graph shows the total number of publications written about "Plasma Kallikrein" by people in this website by year, and whether "Plasma Kallikrein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasma Kallikrein" by people in Profiles.
-
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2108-2121.
-
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728.